Adrenal insufficiency
Gene: CYP11B2
Multiple (>>3) unrelated individuals reported with hypoaldosteronism due to corticosterone methyloxidase type I or II deficiency.
CYP11B2 catalyses both the penultimate and ultimate steps in aldosterone biosynthesis. Variants affecting the penultimate step cause CMO I deficiency, while variants affecting only or predominantly the ultimate step cause CMO II deficiency, and the two overlap phenotypically but have distinct biochemical features (PMID:8772616, 9814506).Created: 21 Sep 2020, 4:47 p.m. | Last Modified: 21 Sep 2020, 4:47 p.m.
Panel Version: 0.4528
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Hypoaldosteronism, congenital, due to CMO I deficiency (MIM#203400) or due to CMO II deficiency (MIM#610600).
Publications
Variants in this GENE are reported as part of current diagnostic practice
Gene: cyp11b2 has been classified as Green List (High Evidence).
gene: CYP11B2 was added gene: CYP11B2 was added to Adrenal insufficiency. Sources: Expert Review Green,Victorian Clinical Genetics Services treatable tags were added to gene: CYP11B2. Mode of inheritance for gene: CYP11B2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: CYP11B2 were set to 8439335; 9360501; 15240589; 9814506; 12788848; 8772616 Phenotypes for gene: CYP11B2 were set to Hypoaldosteronism, congenital, due to CMO I deficiency (MIM#203400) or due to CMO II deficiency (MIM#610600).